Cargando…

Clinical and histopathological factors associated with Ki-67 expression in breast cancer patients

The aim of the present study was to identify the optimal Ki-67 cut-off value in breast cancer (BC) patients, and investigate the association of Ki-67 expression levels with other prognostic factors. Firstly, a retrospective search was performed to identify patients with stage I–III BC (n=462). A ran...

Descripción completa

Detalles Bibliográficos
Autores principales:	ALCO, GUL, BOZDOGAN, ATILLA, SELAMOGLU, DERYA, PILANCI, KEZBAN NUR, TUZLALI, SITKI, ORDU, CETIN, IGDEM, SEFIK, OKKAN, SAIT, DINCER, MAKTAV, DEMIR, GOKHAN, OZMEN, VAHIT
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2015
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4315001/ https://www.ncbi.nlm.nih.gov/pubmed/25663855 http://dx.doi.org/10.3892/ol.2015.2852

Ejemplares similares

Replacement of the tumor bed following oncoplastic breast-conserving surgery with immediate latissimus dorsi mini-flap
por: Alço, Gül, et al.
Publicado: (2016)

The Prognostic Impact of Molecular Subtypes and Very Young Age on Breast Conserving Surgery in Early Stage Breast Cancer
por: Ordu, Cetin, et al.
Publicado: (2016)

True Local Recurrences after Breast Conserving Surgery have Poor Prognosis in Patients with Early Breast Cancer
por: Sarsenov, Dauren, et al.
Publicado: (2016)

Is Administration of Trastuzumab an Independent Risk Factor for Developing Osteonecrosis of the Jaw Among Metastatic Breast Cancer Patients Under Zoledronic Acid Treatment?
por: Pilanci, Kezban Nur, et al.
Publicado: (2015)

LONG-TERM SURVIVAL EFFECTS OF PREOPERATIVE BREAST MRI IN PATIENTS WITH BREAST-CONSERVING SURGERY
por: Ilgun, Ahmet Serkan, et al.
Publicado: (2022)

Comparison of breast cancer patients who underwent partial mastectomy (PM) with mini latissimus dorsi flap (MLDF) and subcutaneous mastectomy with implant (M + I) regarding quality of life (QOL), cosmetic outcome and survival rates
por: Ozmen, Vahit, et al.
Publicado: (2020)

Prognostic relevance of sunitinib toxicities and comparison of continuous vs. intermittent sunitinib dosing schedule in metastatic renal cell cancer patients
por: Ordu, Çetin, et al.
Publicado: (2016)

Tracheomediastinal Fistula in a Patient With Lung Adenocarcinoma and Its Treatment With Argon Plasma Coagulation: A Case Report
por: Ucer, Mehtap, et al.
Publicado: (2014)

Evaluation of Anti-Mullerian Hormone Levels, Antral Follicle Counts, and Mean Ovarian Volumes in Chemotherapy-Induced Amenorrhea among Breast Cancer Patients: A Prospective Clinical Study
por: Ünal, Çağlar, et al.
Publicado: (2023)

Survival results according to Oncotype Dx recurrence score in patients with hormone receptor positive HER-2 negative early-stage breast cancer: first multicenter Oncotype Dx recurrence score survival data of Turkey
por: Ünal, Çağlar, et al.
Publicado: (2023)

The importance of endometrial nerve fibers and macrophage cell count in the diagnosis of endometriosis
por: Cetin, Cihan, et al.
Publicado: (2013)

Importance of multigene panel test in patients with consanguineous marriage and family history of breast cancer
por: Ozmen, Vahit, et al.
Publicado: (2022)

Does Early PET/CT Assesment of Response to Chemotherapy Predicts Survival in Patients With Advanced Stage Non-Small-Cell Lung Cancer?
por: Ordu, Cetin, et al.
Publicado: (2014)

Comparison of Barriers Against Mammography Screening in Socioeconomically Very Low and Very High Populations
por: Ozmen, Tolga, et al.
Publicado: (2016)

MCM-2 Levels as a Potential Biomarker for Predicting High-Risk Breast Cancer Patients According to TAILORx Classification
por: Ünal, Çağlar, et al.
Publicado: (2023)

Ki-67 gene expression
por: Uxa, Sigrid, et al.
Publicado: (2021)

To Ki or Not to Ki: Re-Evaluating the Use and Potentials of Ki-67 for T Cell Analysis
por: Di Rosa, Francesca, et al.
Publicado: (2021)

Corrigendum: To Ki or Not to Ki: Re-Evaluating the Use and Potentials of Ki-67 for T Cell Analysis
por: Di Rosa, Francesca, et al.
Publicado: (2021)

The intrinsically disorderly story of Ki-67
por: Remnant, Lucy, et al.
Publicado: (2021)

Proliferative activity in human breast cancer: Ki-67 automated evaluation and the influence of different Ki-67 equivalent antibodies
por: Fasanella, S, et al.
Publicado: (2011)

Assessment of Ki67 in Breast Cancer: Updated Recommendations From the International Ki67 in Breast Cancer Working Group
por: Nielsen, Torsten O, et al.
Publicado: (2020)

A Risk Assessment Comparison of Breast Cancer and Factors Affected to Risk Perception of Women in Turkey: A Cross-sectional Study
por: YÜKSEL, Serpil, et al.
Publicado: (2017)

Immunolocalization of Ki-67 in different periodontal conditions
por: Preethi, Penubolu Lakshmi, et al.
Publicado: (2014)

Quantum Dots-Based Quantitative and In Situ Multiple Imaging on Ki67 and Cytokeratin to Improve Ki67 Assessment in Breast Cancer
por: Yuan, Jing Ping, et al.
Publicado: (2015)

ki67 nuclei detection and ki67-index estimation: a novel automatic approach based on human vision modeling
por: Barricelli, Barbara Rita, et al.
Publicado: (2019)

Independent Clinical Validation of the Automated Ki67 Scoring Guideline from the International Ki67 in Breast Cancer Working Group
por: Boyaci, Ceren, et al.
Publicado: (2021)

Low correlation between Ki67 assessed by qRT-PCR in Oncotype Dx score and Ki67 assessed by Immunohistochemistry
por: Selmani, Zohair, et al.
Publicado: (2022)

Ki-67 and breast cancer prognosis: does it matter if Ki-67 level is examined using preoperative biopsy or postoperative specimen?
por: Choi, Soon Bo, et al.
Publicado: (2022)

A comparative study between Ki67 positive versus Ki67 negative females with breast cancer: Cross sectional study
por: Bahaddin, Mowafak Masoud
Publicado: (2020)

Primary Adrenal Lymphoma with Secondary Central Nervous System Involvement: A Case Report and Review of the Literature
por: Aydın, Kübra, et al.
Publicado: (2013)

Ki-67 biomarker in breast cancer of Indian women
por: Patil, Amit V., et al.
Publicado: (2011)

Quantifying the Ki-67 Heterogeneity Profile in Prostate Cancer
por: Mesko, Shane, et al.
Publicado: (2013)

Ki-67 Expression in Hydatidiform Moles and Hydropic Abortions
por: Khooei, Alireza, et al.
Publicado: (2013)

Proliferating Trichilemmal Cyst: The Value Of Ki67 Immunostaining
por: Rangel-Gamboa, Lucia, et al.
Publicado: (2013)

The cell proliferation antigen Ki-67 organises heterochromatin
por: Sobecki, Michal, et al.
Publicado: (2016)

Interobserver Variability of Ki-67 Measurement in Breast Cancer
por: Chung, Yul Ri, et al.
Publicado: (2016)

Immunohistochemical detection of Hsp90 and Ki-67 in pterygium
por: Sebastiá, Roberto, et al.
Publicado: (2013)

Ki-67, an elusive marker in the prognosis of breast cancer
por: Sood, Neelam
Publicado: (2019)

The relationship between the expression of Ki-67 and the prognosis of osteosarcoma
por: Zeng, Ming, et al.
Publicado: (2021)

Expression and clinicopathological correlation of Ki-67 in gallbladder carcinoma
por: Gupta, Amit, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4cqef7504oov65gigjju8i815a